Involvement of cyclic adenosine diphosphoribose receptor activation in ischemic preconditioning induced protection in mouse brain

Brain Research

Volumn 1309, Issue , 2010, Pages 75-82

  Rehni, Ashish K ^a   Singh, Thakur Gurjeet ^a   Bhateja, Pradeep ^b   Singh, Nirmal ^c   Arora, Sandeep ^a  

^a CHITKARA UNIVERSITY   (India)

^b Bhojia Dental College & Hospital   (India)

^c PUNJABI UNIVERSITY   (India)

Author keywords

8 Bromo cyclic adenosine diphosphate ribose; Adenosine diphosphoribose receptor; Cerebral Ischemia; Ischemic preconditioning

Indexed keywords

8 BROMO CYCLIC AMP; ADENOSINE DIPHOSPHATE RIBOSE; CYCLIC ADENOSINE DIPHOSPHATE RIBOSE; CYCLIC ADENOSINE DIPHOSPHATE RIBOSE RECEPTOR; RECEPTOR; TRIPHENYLTETRAZOLIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INFARCTION SIZE; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN PERFUSION; BRAIN PROTECTION; CAROTID ARTERY OBSTRUCTION; CONTROLLED STUDY; ISCHEMIC PRECONDITIONING; MAZE TEST; MEMORY DISORDER; MOTOR COORDINATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; TASK PERFORMANCE;

ANIMALS; BRAIN; BRAIN INFARCTION; CAROTID STENOSIS; CYCLIC ADP-RIBOSE; CYTOPROTECTION; DISEASE MODELS, ANIMAL; FEMALE; HYPOXIA-ISCHEMIA, BRAIN; ISCHEMIC PRECONDITIONING; MALE; MEMORY DISORDERS; MICE; MOVEMENT DISORDERS; NEUROPSYCHOLOGICAL TESTS; RECEPTORS, CELL SURFACE; REPERFUSION INJURY;

MUS;

EID: 72049086663     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.10.071     Document Type: Article

References (44)

1. Arrell D.K., Elliott S.T., Kane L.A., Guo Y., Ko Y.H., Pedersen P.L., Robinson J., Murata M., Murphy A.M., Marban E., and Van Eyk J.E. Proteomic analysis of pharmacological preconditioning novel protein targets converge to mitochondrial metabolism pathways. Circ. Res. 99 (2006) 706-714
2. Baker K., Markus C.B., Huffman K., Kruk H., Malfory B., and Doctrow S.R. Synthetic combined superoxide dismutase/catalase mimetics are protective as a delayed treatment in a rat stroke model: a key role for reactive oxygen species in ischemic brain injury. J. Pharmacol. Exper. Ther. 284 (1998) 215-221
3. Banerjee A., Locke W.C., Rogers K.B., Mitchell M.B., Brew E.C., Cairns C.B., Bensard D.D., and Harken A.H. Preconditioning against myocardial dysfunction after ischemia and reperfusion by an alpha 1-adrenergic mechanism. Circ. Res. 73 (1993) 656-670
4. Banerjee S., Walseth T.F., Borgmann K., Wu L., Bidasee K.R., Kannan M.S., and Ghorpade A. CD38/cyclic ADP-ribose regulates astrocyte calcium signaling: implications for neuroinflammation and HIV-1-associated dementia. J. Neuroimmune Pharmacol. 3 3 (2008) 154-164
5. Bickler P.E., Fahlman C.S., Gray J., and McKleroy W. Inositol 1,4,5-triphosphate receptors and NAD(P)H mediate Ca2+ signaling required for hypoxic preconditioning of hippocampal neurons. Neuroscience 160 1 (2009) 51-60
6. Bochelen D., Rudin M., and Sauter A. Calcineurin inhibitors FK506 and SDZ ASM 981 alleviate the outcome of focal cerebral ischemic/reperfusion injury. J. Pharmacol. Exp. Ther. 288 (1999) 653-659
7. Cuzzocrea S., McDonald M.C., Mazzon E., Siriwardena D., Costantino G., Fulia F., Cucinotta G., Gitto E., Cordaro S., Barberi I., De Sarro A., Caputi A.P., and Thiemermann C. Effects of tempol, a membrane-permeable radical scavenger, in a gerbil model of brain injury. Brain Res. 875 (2000) 96-106
8. Dammermann W., Zhang B., Nebel M., Cordiglieri C., Odoardi F., Kirchberger T., Kawakami N., Dowden J., Schmid F., Dornmair K., Hohenegger M., Flügel A., Guse A.H., and Potter B.V. NAADP-mediated Ca2+ signaling via type 1 ryanodine receptor in T cells revealed by a synthetic NAADP antagonist. Proc. Natl. Acad. Sci. U. S. A. 106 26 (2009) 10678-10683
9. Dobkin B.H. The rehabilitation of elderly stroke patients. Clin. Geriat. Med. 7 (1991) 507-523
10. Dunham N.W., and Miya T.S. A note on a simple apparatus for detecting neurological deficit in rats and mice. J. Am. Pharm. Assoc. Am. Pharm. Assoc. (Baltim.) 46 (1957) 208-209
11. Erikson J.M., and Velasco C.E. Endothelin-1 and myocardial preconditioning. Am. Heart J. 132 (1996) 84-90
12. Ferrara A., Bejaoui S.E., Seyen S., Tirelli E., and Plumier J.C. The usefulness of the operant conditioning to assess long-lasting deficits following transient focal ischemia in mice. Behav. Brain Res. (2009) Aug 14. [Epub ahead of print]
13. Goto M., Liu Y., Yang X.M., Ardell J.L., Cohen M.V., and Downey J.M. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ. Res. 77 (1995) 611-621
14. Gupta R., Singh M., and Sharma A. Neuroprotective effect of antioxidants on Ischemia and reperfusion-induced cerebral injury. Pharmacol. Res. 48 (2003) 209-215
15. Higashida H., Salmina A.B., Olovyannikova R.Y., Hashii M., Yokoyama S., Koizumi K., Jin D., Liu H.X., Lopatina O., Amina S., Islam M.S., Huang J.J., and Noda M. Cyclic ADP-ribose as a universal calcium signal molecule in the nervous system. Neurochem. Int. 51 (2007) 192-199
16. Himori N., Wantanabe H., Akaike N., Kurasawa M., ltoh J., and Tanaka Y. Cerebral ischemia model with conscious mice. Involvement of NMDA receptor activation and derangement of learning and memory ability. J. Pharmacol. Methods 23 (1990) 311-327
17. Jenkins L.W., Povlishock J.T., Lewelt W., Miller J.D., and Becker D.P. The role of postischemic recirculation in the development of ischemic neuronal injury following complete cerebral ischemia. Acta Neuropathol. 5 (1981) 205-220
18. Kitagawa K., Matsumoto M., Tagaya M., Hata R., Ueda H., Niinobe M., Handa N., Fukunaga R., Kimura K., and Mikoshiba K. 'Ischemic tolerance' phenomenon found in the brain. Brain Res. 528 (1990) 21-24
19. Kofler J., Sawada M., Hattori K., Dawson V.L., and Hurn P.D. Brain injury after cardiac arrest and cardiopulmonary resuscitation (CPR). In: Krieglstein J. (Ed). Pharmacology of Cerebral Ischemia (2002), Medpharm Scientific Publishers, Stuttgart
20. Laporte R., Hui A., and Laher I. Pharmacological modulation of sarcoplasmic reticulum function in smooth muscle. Pharmacol. Rev. 56 (2004) 439-513
21. Li P.L., Tang W.X., Valdivia H.H., Zou A.P., and Campbell W.B. cADP-ribose activates reconstituted ryanodine receptors from coronary arterial smooth muscle. Am. J. Physiol. 280 (2001) 208-215
22. Liu Y., Tsuchida A., Cohen M.V., and Downey J.M. Pretreatment with angiotensin II activates protein kinase C and limits myocardial infarction in isolated rabbit hearts. J. Mol. Cell. Cardiol. 27 (1995) 883-892
23. Lopatina O., Liu H.X., Amina S., Hashii M., and Higashida H. Oxytocin-induced elevation of ADP-ribosyl cyclase activity, cyclic ADP-ribose or Ca(2+) concentrations is involved in autoregulation of oxytocin secretion in the hypothalamus and posterior pituitary in male mice. Neuropharmacology (2009) [Epub ahead of print] PMID: 19540855
24. Monteiro D., Liu Q., Lisboa S., Scherer G.E., Quader H., and Malhó R. Phosphoinositides and phosphatidic acid regulate pollen tube growth and reorientation through modulation of [Ca2+]c and membrane secretion. J. Exp. Bot. 56 (2005) 1665-1674
25. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J. Neurosci. Methods 11 (1984) 47-60
26. Mullane K., and Bullough D. Harnessing an endogenous cardioprotective mechanism: cellular sources and sites of action of adenosine. J. Mol. Cell. Cardiol. 27 (1995) 1041-1054
27. Murakami K., Konto T., Kawace M., and Chan P.H. The development of a new mouse model of global ischemia: focus on the relationships between ischemia duration, anesthesia, cerebral vasculature and neuronal injury following global ischemia in mice. Brain Res. 780 (1998) 304-310
28. Murray C.E., Jennings R.B., and Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74 (1986) 1124-1136
29. Neumar R.W. Molecular mechanisms of ischemic neuronal injury. Ann. Emerg. Med. 36 (2000) 483-506
30. Rehni A.K., Bhateja P., and Singh N. Diethyl dithiocarbamic acid, a possible nuclear factor kappa B inhibitor, attenuates ischemic postconditioning-induced attenuation of cerebral ischemia-reperfusion injury in mice. Can. J. Physiol. Pharmacol. 87 (2009) 63-68
31. Rehni A.K., Bhateja P., Singh N., and Jaggi A.S. Implication of mast cell degranulation in ischemic preconditioning-induced prevention of cerebral injury. Fundam. Clin. Pharmacol. 22 (2008) 179-188
32. Rehni A.K., Singh T.G., Jaggi A.S., and Singh N. Pharmacological preconditioning of the brain: a possible interplay between opioid and calcitonin gene related peptide transduction systems. Pharmacol. Rep. 60 (2008) 904-913
33. Schultz J.E., Hsu A.K., and Gross G.J. Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart. Circ. Res. 78 (1996) 1100-1104
34. Soares S.M., Thompson M., and Chini E.N. Role of the second-messenger cyclic-adenosine 5′-diphosphate-ribose on adrenocorticotropin secretion from pituitary cells. Endocrinology 146 (2005) 2186-2192
35. Tanaka K., Ohnishi Y., Sato T., and Nishikawa T. Role of ryanodine receptors in hydrogen peroxide-induced DNA fragmentation and thymidine incorporation in cultured rat astrocytes. Nippon Yakurigaku Zasshi 112 (1998) 108-112
36. Traystman R.J. Animal models of focal and global cerebral ischemia. ILAR J. 44 (2003) 85-95
37. Tupling A.R., Bombardier E., Vigna C., Quadrilatero J., and Fu M. Interaction between Hsp70 and the SR Ca2+ pump: a potential mechanism for cytoprotection in heart and skeletal muscle. Appl. Physiol. Nutr. Metab. 33 (2008) 1023-1032
38. 2+ release. Biochim. Biophys. Acta 1178 (1993) 235
39. Wang R.M., Yang F., and Zhang Y.X. Preconditioning-induced activation of ERK5 is dependent on moderate Ca2+ influx via NMDA receptors and contributes to ischemic tolerance in the hippocampal CA1 region of rats. Life Sci. 79 (2006) 1839-1846
40. Whisnant J.H. The decline of stroke. Stroke 15 (1984) 160-168
41. Yamamoto Y., Shioda N., Han F., Moriguchi S., Nakajima A., Yokosuka A., Mimaki Y., Sashida Y., Yamakuni T., Ohizumi Y., and Fukunaga K. Nobiletin improves brain ischemia-induced learning and memory deficits through stimulation of CaMKII and CREB phosphorylation. Brain Res. (2009) Jul 30. [Epub ahead of print]
42. Yao Z., and Gross G.J. Acetylcholine mimics ischemic preconditioning via a glibenclamide-sensitive mechanism in dogs. Am. J. Physiol. 264 (1993) H2221-H2225
43. Yao Z., and Gross G.J. Role of nitric oxide, muscarinic receptors, and the ATP-sensitive Kq channel in mediating the effects of acetylcholine to mimic preconditioning in dogs. Circ. Res. 73 (1993) 1193-1201
44. Ying W. NAD+ and NADH in brain functions, brain diseases and brain aging. Front. Biosci. 12 (2007) 1863-1888